Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$52.0 - $120.21 $5,304 - $12,261
102 Added 0.78%
13,179 $1.21 Million
Q2 2021

Aug 16, 2021

BUY
$31.88 - $58.66 $189,717 - $349,085
5,951 Added 83.51%
13,077 $693,000
Q1 2021

May 14, 2021

SELL
$28.6 - $49.21 $200,829 - $345,552
-7,022 Reduced 49.63%
7,126 $256,000
Q3 2020

Nov 13, 2020

BUY
$39.85 - $57.3 $179,325 - $257,850
4,500 Added 46.64%
14,148 $707,000
Q2 2020

Aug 14, 2020

BUY
$34.93 - $57.75 $337,004 - $557,172
9,648 New
9,648 $446,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.